Glomerulonephritis, IGA: Clinical Trials

12 trials for Glomerulonephritis, IGA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 12

Follow Glomerulonephritis, IGA: new trials by email Literature Review of Glomerulonephritis, IGA trials Research Report on Glomerulonephritis, IGA

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rituximab and RASi in Patients with IgAN
Rituximab, RAS 2410 - IgA Nephropathy
Phase 4CompletedNan Chen,MD1162020-07-012025-03-14
Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study
Hydroxychloroquine Sulfate - Primary IgA Nephropathy
Phase 4CompletedLLiu202015-01-012015-12-17
Pilot Study of VelcadeĀ® in IgA Nephropathy
Bortezomib (VelcadeĀ®) - Chronic Kidney Disease, IgA Nephropathy
Phase 4CompletedThe Rogosin Institute112010-07-012018-11-16
Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
ACTHAR gel - Treatment Resistant Nephrotic Syndrome
Phase 4CompletedColumbia University152009-12-012014-04-24
Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade
Aliskiren - IgA Nephropathy
Phase 4CompletedThe University of Hong Kong252009-07-012015-07-03
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
Intravenous Rituximab, ACE/ARB, Omega-3 Fatty Acid Fish Oil Supplement - IgA Nephropathy
Phase 4CompletedMayo Clinic342009-02-012017-02-01
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Valsartan, Probucol, Placebo - Glomerulonephritis, IGA Nephropathy
Phase 4CompletedGuangdong Provincial People's Hospital752007-05-012013-08-28
Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy
Calcitriol - IGA Nephropathy
Phase 4CompletedChinese University of Hong Kong102006-05-012009-01-30
Mycophenolate Mofetil for IgA Nephropathy
mycophenolate mofetil, angiotensin blockade - IGA Nephropathy
Phase 4CompletedThe University of Hong Kong402002-03-012009-03-17
"Steroids and Azathioprine Versus Steroids Alone in IgAN"
steroids plus azathioprine, steroids - IGA Nephropathy
Phase 4CompletedA. Manzoni Hospital2061998-05-012008-09-19
Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
Ramipril or losartan - IGA Glomerulonephritis
Phase 4CompletedUniversity Magna Graecia201997-01-012010-05-04
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
ENALAPRIL VALSARTAN METHYLPREDNISONE - IGA Nephropathy
Phase 4CompletedHospital Britanico201996-01-012006-11-01

Narrower conditions

Proteinuria (9)  ·  Glomerulonephritis (2)  ·  Renal Insufficiency, Chronic (2)  ·  Glomerulonephritis, Membranous (1)  ·  Glomerulosclerosis, Focal Segmental (1)  ·  Kidney Failure, Chronic (1)  ·  Nephrosis, Lipoid (1)  ·  Nephrotic Syndrome (1)

Broader conditions

Autoimmune Diseases (12)  ·  Female Urogenital Diseases (12)  ·  Female Urogenital Diseases and Pregnancy Complications (12)  ·  Immune System Diseases (12)  ·  Kidney Diseases (12)  ·  Male Urogenital Diseases (12)  ·  Nephritis (12)  ·  Urogenital Diseases (12)  ·  Urologic Diseases (12)  ·  Glomerulonephritis (10)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (9)  ·  Urination Disorders (9)  ·  Urological Manifestations (9)  ·  Chronic Disease (3)

Interventions

Rituximab (2)  ·  Adenosine Triphosphate (1)  ·  Azathioprine (1)  ·  Bortezomib (1)  ·  Calcitriol (1)  ·  Hydroxychloroquine (1)  ·  Losartan (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Mycophenolic Acid (1)  ·  Probucol (1)  ·  Ramipril (1)  ·  Renin-Angiotensin System (1)  ·  Steroids (1)  ·  Valsartan (1)  ·  aliskiren (1)

Sponsors

The University of Hong Kong (2)  ·  A. Manzoni Hospital (1)  ·  Chinese University of Hong Kong (1)  ·  Columbia University (1)  ·  Guangdong Provincial People's Hospital (1)  ·  Hospital Britanico (1)  ·  LLiu (1)  ·  Mayo Clinic (1)  ·  Nan Chen,MD (1)  ·  The Rogosin Institute (1)  ·  University Magna Graecia (1)

Countries

China (5)  ·  United States (3)  ·  Italy (2)  ·  Argentina (1)  ·  Hong Kong (1)  ·  Switzerland (1)

Top investigators

Antonello Pani, MD (1)  ·  Cheuk-Chun Szeto, MD (1)  ·  Choli Hartono, MD (1)  ·  Claudio Ponticelli, MD (1)  ·  Claudio Pozzi, MD (1)  ·  Fernando C. Fervenza, M.D. (1)  ·  Francesco Locatelli, MD (1)  ·  Gerald B Appel, MD (1)  ·  Gian B Fogazzi, MD (1)  ·  Giorgio Fuiano, Professor (1)  ·  Hong Zhang, PhD,MD (1)  ·  Jingyuan Xie (1)  ·  Paolo Altieri, MD (1)  ·  Simeone Andrulli, MD (1)  ·  Sydney CW Tang, MD (1)

Results publications

PMID 26032537, PMID 38299639, PMID 16014059, PMID 18436082, PMID 21680850, PMID 22075320, PMID 22722778, PMID 24009220, PMID 24191893, PMID 24641955, PMID 27821627, PMID 29988921